Tower Research Capital (TRC)’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-6,736
| Closed | -$182K | – | 6072 |
|
2024
Q2 | $182K | Buy |
6,736
+5,848
| +659% | +$158K | ﹤0.01% | 2152 |
|
2024
Q1 | $16.3K | Sell |
888
-6,946
| -89% | -$127K | ﹤0.01% | 3197 |
|
2023
Q4 | $96.1K | Buy |
7,834
+6,165
| +369% | +$75.6K | ﹤0.01% | 2670 |
|
2023
Q3 | $25K | Sell |
1,669
-346
| -17% | -$5.19K | ﹤0.01% | 3171 |
|
2023
Q2 | $65.5K | Sell |
2,015
-14,638
| -88% | -$476K | ﹤0.01% | 2342 |
|
2023
Q1 | $652K | Buy |
16,653
+16,320
| +4,901% | +$639K | 0.02% | 685 |
|
2022
Q4 | $18K | Sell |
333
-2,854
| -90% | -$154K | ﹤0.01% | 3248 |
|
2022
Q3 | $143K | Buy |
3,187
+1,934
| +154% | +$86.8K | ﹤0.01% | 2238 |
|
2022
Q2 | $45K | Buy |
1,253
+844
| +206% | +$30.3K | ﹤0.01% | 3000 |
|
2022
Q1 | $17K | Sell |
409
-6,847
| -94% | -$285K | ﹤0.01% | 3721 |
|
2021
Q4 | $309K | Buy |
7,256
+4,748
| +189% | +$202K | 0.01% | 1460 |
|
2021
Q3 | $138K | Sell |
2,508
-1,353
| -35% | -$74.4K | ﹤0.01% | 2133 |
|
2021
Q2 | $184K | Sell |
3,861
-78
| -2% | -$3.72K | ﹤0.01% | 1992 |
|
2021
Q1 | $200K | Buy |
3,939
+2,537
| +181% | +$129K | ﹤0.01% | 2016 |
|
2020
Q4 | $88K | Sell |
1,402
-27,839
| -95% | -$1.75M | ﹤0.01% | 2480 |
|
2020
Q3 | $1.97M | Buy |
29,241
+25,535
| +689% | +$1.72M | 0.02% | 409 |
|
2020
Q2 | $155K | Buy |
+3,706
| New | +$155K | 0.01% | 2038 |
|
2020
Q1 | – | Sell |
-1,024
| Closed | -$41K | – | 4090 |
|
2019
Q4 | $41K | Buy |
1,024
+466
| +84% | +$18.7K | ﹤0.01% | 1469 |
|
2019
Q3 | $18K | Buy |
+558
| New | +$18K | ﹤0.01% | 2555 |
|